CG Oncology, Inc. Common stockCGONNASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank92
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Latest
6.89%
↑ 140% vs avg
Percentile
P92
Near historical high
Streak
1 qtr
Consecutive growthAccelerating
Average
-17.12%
Historical baseline
PeriodValue
Q4 20256.89%
Q3 2025-39.11%
Q2 20254.50%
Q1 2025-41.69%
Q4 2024-29.79%
Q3 20241.25%
Q2 202438.03%
Q1 2024-61.96%
Q4 2023-48.08%
Q3 2023-0.56%
Q2 2023-35.06%
Q1 2023-16.94%
Q4 20220.00%